A recent study published in the Archives of General Psychiatry, in connection with the Journal of the American Medical Association, by Dr. Lisa A. Croen (et al.) has revealed a connection between mothers who use selective serotonin-reuptake inhibitors, (SSRIs – a new type of antidepressant medication) and the development of Autism Spectrum Disorder in their children.
Examples of commonly-used SSRI drugs include Zoloft, Prozac, Paxil, Celexa, and Lexapro.
The Croen team gathered data by surveying 298 mothers of children with Autism Spectrum Disorder with regard to their use of medication during pregnancy, and comparing the medication use reported by those mothers to that of 1507 other mothers whose children were born without Autism Spectrum Disorder.
Through statistical analyses, it was found that children born to mothers who used SSRIs during pregnancy were twice as likely to be born with Autism Spectrum Disorder, compared to children born to mothers who had not used SSRI drugs during pregnancy.[1]
Children born to mothers who used SSRI drugs such as Zoloft during the first trimester of pregnancy, were found to be at an even greater risk of being born with Autism Spectrum Disorder – nearly four times greater than the risk faced by children whose mothers had not used SSRI drugs at all during pregnancy.[2]
If you or a loved one used SSRI drugs such as Zoloft during pregnancy and your child now suffers from Autism Spectrum disorder, you may be entitled to compensation from a Zoloft lawsuit. Our Zoloft lawyers have the experience and tools required to help protect your rights. Contact Justinian Lane by phone at (855) 452-5529 or by e-mail at justinian@dangerousdrugs.us for a free consultation. We are here to help.
[1] Croen, L.A., et al. (2011) “Antidepressant Use During Pregnancy and Childhood Autism Spectrum Disorders” Arch Gen Psychiatry Vol. 68, No. 11. November, 2011. p. 1104-1112
[2] Croen, L.A., et al. (2011) “Antidepressant Use During Pregnancy and Childhood Autism Spectrum Disorders” Arch Gen Psychiatry Vol. 68, No. 11. November, 2011. p. 1104-1112